The role of PET in the first-line treatment of the most common subtypes of non-Hodgkin lymphoma

SF Barrington, J Trotman - The Lancet Haematology, 2021 - thelancet.com
This Review focuses on the use of 18 F-fluorodeoxyglucose (18 F-FDG) PET in the
assessment of diffuse large B-cell lymphoma, follicular lymphoma, and peripheral T-cell …

Integration of PET in DLBCL

KL Lewis, J Trotman - Seminars in Hematology, 2023 - Elsevier
F-fluorodeoxyglucose positron emission tomography-computerized tomography (18 FDG-
PET/CT) is the gold-standard imaging modality for staging and response assessment for …

Long-term results of PET-guided radiation in patients with advanced-stage diffuse large B-cell lymphoma treated with R-CHOP

CL Freeman, KJ Savage, DR Villa… - Blood, The Journal …, 2021 - ashpublications.org
Consolidative radiation therapy (RT) for advanced-stage diffuse large B-cell lymphoma
(DLBCL) remains controversial, with routine practice continuing to include RT in patients …

18F-FDG PET/CT in lymphoma: has imaging-directed personalized medicine become a reality?

SF Barrington, PWM Johnson - Journal of Nuclear Medicine, 2017 - Soc Nuclear Med
PET/CT using 18F-FDG is an essential part of the management of patients with lymphoma.
Efforts to standardize PET acquisition and reporting, including the 5-point Deauville scale …

The Role of positron emission tomography imaging in radiotherapy target delineation

H Menon, C Guo, V Verma, CB Simone - PET clinics, 2020 - pet.theclinics.com
Until relatively recently, the ability to diagnose and treat cancer with radiation therapy (RT)
has been largely based on anatomy, without consideration of metabolic or dynamic …

Impact on survival through consolidation radiotherapy for diffuse large B-cell lymphoma: a comprehensive meta-analysis

MD Berger, S Trelle, AE Büchi, S Jegerlehner… - …, 2020 - pmc.ncbi.nlm.nih.gov
Rituximab has improved response rates and overall survival in diffuse large B-cell
lymphoma. Radiotherapy is an effective treatment modality for lymphomas, but there is …

Outcomes of adults with lymphoma treated with nonmyeloablative TLI-ATG and radiation boost to high risk or residual disease before allogeneic hematopoietic cell …

ML Dworkin, AL Jiang, R Von Eyben… - Bone Marrow …, 2022 - nature.com
We evaluated the impact on survival of antithymocyte globulin conditioning (TLI-ATG) with
radiation (RT) boost to high risk or residual disease before allogeneic hematopoietic cell …

My burning issues in aggressive Non Hodgkin's Lymphoma

D Fuchs, MA Fridrik - memo-Magazine of European Medical Oncology, 2018 - Springer
Combined-modality treatment with chemo-immunotherapy and radiotherapy produces
excellent outcomes in early-stage, non-bulky diffuse large B‑cell lymphoma, and reducing …